3 results match your criteria: "Banner Health-University of Arizona College of Medicine[Affiliation]"
Medical Device Malfunction Reporting.
Am J Gastroenterol
October 2024
Division of Gastroenterology, Emory University Medical Center, Atlanta, Georgia, USA.
In Search of the Holy Grail of Artificial Hearts: Are We There Yet?
Semin Thromb Hemost
February 2024
Advanced Heart Program, Department of Surgery and Medicine, Banner Health-University of Arizona College of Medicine, Phoenix, Arizona.
The total artificial heart (TAH) has a long and rich history, being the product of decades of innovation, hard work, and dedication. This review examines the history of the TAH, a device that has revolutionized the treatment of end-stage biventricular heart failure. It reviews the development of the device from early concepts to the current state-of-the-art device, the SynCardia TAH, which has been implanted in over 2,000 patients worldwide.
View Article and Find Full Text PDFMolecular Imaging of Glucose Metabolism for Intraoperative Fluorescence Guidance During Glioma Surgery.
Mol Imaging Biol
August 2021
Department of Neurosurgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ, USA.
Purpose: This study evaluated the use of molecular imaging of fluorescent glucose analog 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose (2-NBDG) as a discriminatory marker for intraoperative tumor border identification in a murine glioma model.
Procedures: 2-NBDG was assessed in GL261 and U251 orthotopic tumor-bearing mice. Intraoperative fluorescence of topical and intravenous 2-NBDG in normal and tumor regions was assessed with an operating microscope, handheld confocal laser scanning endomicroscope (CLE), and benchtop confocal laser scanning microscope (LSM).